ArticleAlimentary pharmacology & therapeutics2022
Editorial: the immunogenicity to second anti-TNF therapy (IMSAT) therapeutic drug monitoring study-defining the risk of the in-class switch.
Aze Suzanne WilsonPubMed ↗Publisher ↗
No numbers read from the abstract.